Lisavanbulin in patients with recurrent glioblastoma: Phase 2a results and a consolidated analysis of response-predictive biomarkers.

Juanita Lopez, Joachim P. Steinbach, Ruth Plummer et al.|Journal of Clinical Oncology|2023

Cited by 1